Project
I6T-MC-AMAM
Automatically Closed · 2019 until 2022
Brand Stephan, Sulz Michael, Smolders Jolijn, Krieger-Grübel Claudia
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2019
End Date
2022
Financing
Industry
Brief description/objective
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-
Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease